Aoife Brennan Eliem Therapeutics, Inc. (ELYM) insider trading activity

ELYM Quotes by TradingView

Aoife Brennan is President and CEO of Eliem Therapeutics, Inc.. Currently has a direct ownership of 48,132 shares of ELYM, which is worth approximately $197,822. The most recent transaction as insider was on Jun 30, 2025, when has been sold 20,618 shares (Common Stock) at a price of $1.22 per share, resulting in proceeds of $25,153. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.1K
n/a 3M change
n/a 12M change
Total Value Held $197,822

Aoife Brennan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
SELL
Open market or private sale
$25,153 $1.22 p/Share
20,618 Reduced 29.99%
48,132 Common Stock
Jun 27 2025
BUY
Exercise of conversion of derivative security
-
68,750 Added 50.0%
68,750 Common Stock

Also insider at

SYBX
SYNLOGIC, INC. Healthcare
President and CEO
FGEN
FIBROGEN INC Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
AB

Aoife Brennan

President and CEO
San Francisco, CA

Track Institutional and Insider Activities on ELYM

Follow Eliem Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELYM shares.

Notify only if

Insider Trading

Get notified when an Eliem Therapeutics, Inc. insider buys or sells ELYM shares.

Notify only if

News

Receive news related to Eliem Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELYM